Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with XGES.L. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.
Cheapest Alternatives to XGES.L
XGES.L charges 0.35% annually. There are 14 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.12%.
| Symbol | Name | Expense Ratio | AUM | Inception | |
|---|---|---|---|---|---|
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 0.12% | 644.55M | Sep 2017 | XGES.L vs XSHC.L | |
| Invesco US Health Care Sector UCITS ETF | 0.14% | 343.20M | Dec 2009 | XGES.L vs XLVP.L | |
| Invesco Health Care S&P US Select Sector UCITS ETF... | 0.14% | 461.66M | Dec 2009 | XGES.L vs XLVS.L | |
| iShares S&P 500 Health Care Sector UCITS ETF USD (... | 0.15% | 2.55B | Jun 2020 | XGES.L vs IUHC.L | |
| SPDR S&P US Health Care Select Sector UCITS ETF | 0.15% | — | Jul 2015 | XGES.L vs GXLV.L |
Best Risk-Adjusted Alternatives to XGES.L
XGES.L has a PortfoliosLab risk / return rank of 37. There are 10 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 76.
| Symbol | Name | Risk / Return Rank | AUM | Inception | |
|---|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF | 76 | 624.54M | Oct 2017 | XGES.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | 72 | 55.04M | Mar 2018 | XGES.L vs BTEE.L | |
| Invesco Nasdaq Biotech UCITS ETF | 72 | 407.93M | Nov 2014 | XGES.L vs SBIO.L | |
| Global X Genomics & Biotechnology UCITS ETF | 62 | 20.00M | Nov 2021 | XGES.L vs GNOG.L | |
| WisdomTree BioRevolution UCITS ETF USD Acc | 61 | 12.52M | Dec 2021 | XGES.L vs WBIO.L |
Top Performing XGES.L Alternatives (YTD)
XGES.L is at -0.81% YTD. There are 11 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 12.27%.
| Symbol | Name | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|
| Global X Genomics & Biotechnology UCITS ETF | 12.27% | 20.00M | Nov 2021 | XGES.L vs GNOG.L | |
| WisdomTree BioRevolution UCITS ETF USD Acc | 10.42% | 12.52M | Dec 2021 | XGES.L vs WBIO.L | |
| First Trust NYSE Arca Biotechnology UCITS ETF Acc | 8.97% | 9.55M | May 2020 | XGES.L vs FBT.L | |
| iShares Nasdaq US Biotechnology UCITS ETF | 4.86% | 624.54M | Oct 2017 | XGES.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | 4.58% | 55.04M | Mar 2018 | XGES.L vs BTEE.L |
Lowest Volatility Alternatives to XGES.L
XGES.L has 17.84% 1-year volatility. There are 15 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 13.70%.
| Symbol | Name | Volatility 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| SPDR MSCI World Health Care UCITS ETF | 13.70% | — | Apr 2016 | XGES.L vs HEAW.L | |
| Lyxor UCITS MSCI World Health Care TR C-USD | 14.52% | 913.84M | Aug 2010 | XGES.L vs HLTW.L | |
| Xtrackers MSCI World Health Care UCITS ETF 1C | 14.57% | 3.40B | Mar 2016 | XGES.L vs XDWH.L | |
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 14.72% | 644.55M | Sep 2017 | XGES.L vs XSHC.L | |
| Invesco US Health Care Sector UCITS ETF | 14.76% | 343.20M | Dec 2009 | XGES.L vs XLVP.L |
Lowest Drawdown Alternatives to XGES.L
XGES.L has a 1-year max drawdown of -15.29%. There are 22 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as -6.89%.
| Symbol | Name | Max Drawdown 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF | -6.89% | 624.54M | Oct 2017 | XGES.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | -7.63% | 55.04M | Mar 2018 | XGES.L vs BTEE.L | |
| Invesco Nasdaq Biotech UCITS ETF | -7.64% | 407.93M | Nov 2014 | XGES.L vs SBIO.L | |
| L&G Pharma Breakthrough UCITS ETF | -9.93% | 14.12M | Jan 2018 | XGES.L vs BIGT.L | |
| Lyxor UCITS MSCI World Health Care TR C-USD | -10.12% | 913.84M | Aug 2010 | XGES.L vs HLTW.L |
Other ETFs from DWS
The 10 most viewed DWS ETFs shown here include XDEM.L, XDEV.L, XNGS.L and span 8 categories. AUM among these funds goes as high as $4B.
Often Compared With XGES.L
Investors most often compare XGES.L with XDWT.L, WHCE.L, HLTH.L. These 6 comparison targets span 3 categories, based on PortfoliosLab usage data.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|---|---|
| Xtrackers MSCI World Information Technology UCITS ... | Technology Equities | 68 | 24.10% | 6.35B | Mar 2016 | XGES.L vs XDWT.L | |
| Invesco S&P World Health Care ESG UCITS ETF Acc | Health & Biotech Equities | 22 | -4.23% | — | Apr 2023 | XGES.L vs WHCE.L | |
| SPDR® MSCI Europe Health Care UCITS ETF | Health & Biotech Equities | 15 | -1.46% | 513.47M | Dec 2014 | XGES.L vs HLTH.L | |
| Xtrackers MSCI Japan ESG Screened UCITS ETF 1D | Japan Equities | 67 | 15.48% | 351.95M | Mar 2015 | XGES.L vs XDNS.L | |
| iShares Healthcare Innovation UCITS ETF USD (Acc) | Health & Biotech Equities | 37 | 1.01% | 757.88M | Sep 2016 | XGES.L vs DRDR.L | |
| KraneShares MSCI All China Health Care Index UCITS... | Health & Biotech Equities | 6 | -10.68% | 1.50M | Jan 2021 | XGES.L vs KURE.L |
Compare XGES.L with Any Fund or Stock
Compare XGES.L with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.
Pair XGES.L with funds that move differently
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to XGES.L.
Explore XGES.L Diversifiers